Community Outreach & Education Programs

APSTA, the Association for Psychedelic Science and Therapy Austria, is based in Vienna and describes itself as Austria's leading network for experts in psychedelic research and therapy. It serves medical, psychotherapeutic, psychological, and other professional audiences, with a stated focus on connecting professionals and sharing knowledge, best practices, and experience. Its core activities center on networking, setting guidelines and standards, and education and outreach. APSTA presents itself as a professional association focused on safe, responsible, and evidence-based use of psychedelic substances in therapy and research. Its role appears primarily educational and field-building rather than legislative, with emphasis on ethical practice, public information, and interdisciplinary exchange. Documented examples on its site include supporting research projects, promoting standards for therapy and research, and informing the public about opportunities and risks of psychedelic therapies.

Awareness Lectures on Psychedelics in Switzerland organizes events and conferences that help clinicians and researchers deepen their knowledge of psychedelic literature and future developments.

UC Berkeley Center for the Science of Psychedelics (BCSP), founded in September 2020 by a multidisciplinary faculty group including neuroscientist Michael Silver and author Michael Pollan, conducting psilocybin research into cognition, perception, emotion, and their neural bases in the human brain. BCSP's four pillars of basic science, journalism, culture, and community have established it as a leading interdisciplinary hub for psychedelic research and public engagement, producing The Microdose newsletter and a global clinical trials map.

Cepda, or Center for Psykedelisk Dannelse, is a Danish nonprofit based in Denmark that presents itself as a community, education, and support organization working to build a more responsible, evidence-informed approach to psychedelics. Its website says it builds bridges between research, practitioners, users, and decision-makers, and it operates public-facing educational content, an online community, and in-person or online sharing circles. In the psychedelic field, Cepda is primarily a public education and advocacy-oriented stakeholder rather than a clinical provider. It publishes explainer content on psychedelic therapy, microdosing, tripsitting, and integration, maintains a free project database of Danish student research, and highlights collaboration with Danish and international research actors through its research page. The organization also frames its work around social integration of psychedelics and community support, which suggests practical alignment with researchers, clinicians, funders, policy groups, and patient or user communities seeking education, safe-use resources, and field-building partnerships.

Chacruna is a nonprofit psychedelic education and advocacy platform based in the United States with global reach through online publishing, courses, conferences, and multilingual programming. Its work centers on psychedelic plant medicines, ethics, cultural justice, reciprocity, and Indigenous knowledge, with content and activities aimed at researchers, clinicians, educators, policy audiences, and the broader public. The organization says it bridges ceremony and science and makes academic knowledge more accessible through public-facing education. Chacruna plays an explicit role in psychedelic justice and policy-adjacent advocacy by foregrounding cultural context, equity, and protection of sacred plants and traditions. Current documented initiatives include the Indigenous Reciprocity Initiative of the Americas, which supports community-led Indigenous projects, the Psychedelic Culture conference, the bilingual Chacruna Latinoamérica platform, and courses on diversity, culture, social justice, ceremony, ethics, and reciprocity. These activities make it a potential partner for researchers, clinicians, funders, and policy groups seeking cultural consultation, educational programming, and community-centered collaboration.

DecriminalizeSF is a grassroots organization in San Francisco, California that advocates for the decriminalization of natural psychedelics, such as psilocybin and ayahuasca, and plant medicines. The organization works to raise awareness about the therapeutic potential of these substances and to bui…

Community organization focused on outreach and public education related to psychedelic topics.

Decriminalize Nature is a U.S.-based grassroots network that works through national support and local chapters in cities, states, and some international locations listed on its site, including chapters in places such as California, Michigan, Minnesota, France, and Canada. Its core activities include community organizing, public education, local campaign building, and encouraging local governments to change policy around entheogenic plants and fungi. The organization says its local chapters are the primary vehicle for change and that chapters build awareness, educate the public, and propose legislation. In psychedelic policy, Decriminalize Nature focuses on decriminalization and expanded access for entheogenic plants and fungi, with a stated emphasis on direct political action and local change rather than expensive ballot-driven approaches. Its site describes a five-point plan aimed at incorporating reverence, social equity, and community-serving markets into policy discussions, and its organizer materials support local campaigns and legislation efforts. Potential collaboration areas include local policy work, public education, research-informed advocacy, and coalition building with clinicians, funders, patient communities, and reform groups that want to support access-focused civic campaigns.

Psychedelic media publication covering education, culture, policy, and practical guidance around psychedelic use and integration.

The Finnish Association for Psychedelic Studies is a multidisciplinary association promoting psychedelic research and accessible, research-based information.

Specialized psychedelic clinical trial services provider focused on therapist and facilitator training, protocol/manual support, adherence frameworks, and sponsor-facing trial preparation.

TAIP is an Estonian organization advancing science-based approaches to the use of psychedelics in contemporary therapeutic practices.

Fundación inawe is a Spain-based nonprofit that focuses on mental health innovation and the development of an ecosystem for psychedelic-assisted therapies in Spain. Its official site presents it as a public-facing organization centered on psychedelic science, education, and access-related information for Spanish audiences. The organization appears to operate primarily in Spain, with content oriented to Spanish-language readers and European psychedelic policy developments. Fundación inawe is explicitly engaged in psychedelic medicine and access advocacy through public education, policy-aware commentary, and promotion of initiatives linked to regulated therapeutic use. On its site, it has highlighted the European citizen initiative PsychedeliCare Spain, the European Parliament group on psychedelic-assisted therapy, and coverage of EMA priority-status developments, suggesting a role as an education and mobilization hub rather than a direct clinical provider. Potential collaboration areas include researcher outreach, clinician education, funder engagement, and policy coordination around evidence-based access pathways and implementation in Spain and the EU.

HYSTELICA is a women-focused psychedelic research and education organization based in London, United Kingdom, with activity that appears to extend beyond the UK through its online content and academic collaborations. Its public-facing materials describe it as a non-profit, while UK company records identify HYSTELICA LTD as an active private limited company incorporated in 2022 with a London registered office. The organization says it serves women, people assigned female at birth, practitioners, researchers, and psychonauts seeking sex- and gender-aware psychedelic information. Its role in the field is centered on female biology, women’s mental health, and safer psychedelic use, with particular attention to menstruation, menopause, pregnancy, infertility, contraception, and other sex-specific considerations. Documented current projects include two recruiting studies run with King’s College London, on microdosing and menopausal symptoms and on female psychedelic use, plus a published paper on females in psychedelic research. It also offers educational programming and webinars, and has run a women’s retreat collaboration, which suggests potential partnership opportunities for researchers, clinicians, funders, policy groups, and patient communities interested in women-specific evidence, education, and harm-reduction-oriented access.

HoloMind is a Poland-based psychedelic education and therapy initiative centered on public information, training, and counseling related to therapeutic psychedelic use. Its site describes an educational portal, live and online trainings, and a counseling-oriented practice, and it also states that the group is creating a HoloMind Foundation and an Institute of Psychedelic Therapy. The organization appears to serve Polish audiences, with some materials and programs also framed for broader international outreach. In the psychedelic medicine and policy space, HoloMind positions itself around safer and more informed use, psychedelic integration, and improving access to knowledge about therapeutic pathways in Poland. Documented activities include education on the legal status of psychedelics in Poland, workshops on psychedelic integration, a supervision and intervention group, a 2025 therapy and integration conference, and content on veterans with depression and PTSD. It also references collaboration with other training and education partners, which suggests a field-building role for clinicians, researchers, funders, patient communities, and policy-oriented partners interested in education, implementation, and access.

ICEERS is a Spain-based nonprofit focused on the globalization of Indigenous plant medicines, with work spanning education, research, legal support, and community services. Its website describes three connected areas of work: mitigating harms and consequences, co-creating collaborative pathways, and international monitoring and research. The organization serves people navigating psychoactive plant use, health professionals, and Indigenous and community partners across multiple countries. In psychedelic and drug policy work, ICEERS combines harm reduction, public education, and policy advocacy rather than operating as a patient-access organization. Its current public-facing services include free integration and crisis support through El Faro, a drug-interaction information service, educational resources, and legal defense support for people facing prosecution related to traditional medicines. ICEERS also reports work with Indigenous partners and claims its efforts have informed court rulings and public policy, making it relevant to researchers, clinicians, funders, policy groups, and community stakeholders seeking evidence, safety, and rights-based collaboration.

Hugvíkkandi, the Icelandic Psychedelic Society, is an Iceland-based membership organization founded in Reykjavík in September 2022. It describes itself as a platform for people interested in psychedelics to build community, strengthen advocacy, and learn about the topic, with an aim to support research, legal progress, and international collaboration. Its public-facing work centers on education, awareness-building, and policy or legal reform around psychedelics, with an explicit interest in strengthening ties to similar groups abroad. The organization has hosted or promoted educational programming in Iceland, including a MAPS educational program in November 2023 and a March 2024 workshop on psychedelic-assisted therapy, and it has published content discussing psilocybin use in cancer and end-of-life care.

The Institute of Psychedelic Therapy (IPT) is a UK-based professional training organization offering a comprehensive two-year psychedelic-assisted therapist training program combining weekly online lectures, in-person meetings, and 5-day experiential residential retreats each year. IPT emphasizes slow, relational skill cultivation, robust ethics, and integration of psychedelic work within long-term therapeutic frameworks, with graduates eligible for professional membership.

Kykeon, also presented as the Greek Psychedelic Society, is a Greece-based nonprofit collective focused on education, advocacy, policy, and community building around psychedelics. Its public materials describe work to mobilize a national movement, reduce stigma, and support safe, equitable, and inclusive access to psychedelic-assisted therapies and other healing modalities in Greece. The organization says it serves the Greek public, people interested in psychedelics, and a broader national dialogue on drug policy and altered states of consciousness. Its public-facing role centers on policy reform and public education rather than direct clinical service delivery. The group says it disseminates scientific information, supports reform of the Greek legal framework around psychedelics, hosts dialogues and integration circles, maintains a directory of therapists trained in psychedelic-related modalities, and curates harm-reduction information. Current site content also shows ongoing publishing and issue framing on topics such as psilocybin, harm reduction, medical uses, and international policy developments, which suggests a field role in public awareness, community convening, and reform-oriented advocacy.

Online-first psychedelic journalism outlet focused on digital reporting, commentary, and analysis across science, policy, and culture.

MAPS, the Multidisciplinary Association for Psychedelic Studies, is a U.S.-based 501(c)(3) nonprofit research and educational organization founded in 1986. It works nationally and with a broader global audience to develop medical, legal, and cultural contexts for the careful use of psychedelics and marijuana. Its core activities include research, education, advocacy, and convening the field through large public events. In psychedelic medicine and policy, MAPS positions itself as an advocate for legal access, drug policy reform, harm reduction, and health equity. Its Policy & Advocacy work includes legislative advocacy, community organizing, and impact litigation, and it has also launched work on access for system-impacted people and broader health equity in the legal psychedelic ecosystem. Current documented initiatives include the Psychedelic Science conference series, the Health Equity Program, The Zendo Project, and Ask MAPS, which handles public inquiries about therapy, research, and policy reform.

MAPS Italia is a nonprofit organization founded in 2024 and based in Italy. Its public-facing mission is to promote informed dialogue about the therapeutic use of psychedelic substances, with an emphasis on evidence-based information, education, and a scientific perspective. The organization says it serves people interested in psychedelic medicine, as well as health professionals and the broader Italian public. MAPS Italia positions itself as an educational and advocacy-oriented stakeholder in psychedelic medicine rather than a clinical provider. Its website describes work on public information, events, publications, and professional training, including an international MDMA-assisted therapy training planned for Italy in 2026 and a 2024 conference on the clinical use of psychedelic substances. It also references broader European policy interest, including the 2025 Psychedelicare.eu European Citizens' Initiative, suggesting a role in awareness-building and policy-facing dialogue around regulated therapeutic access.

The National Association for Psychedelic Research in Serbia is a Serbia-based nonprofit association focused on psychedelic research, education, advocacy, and community engagement. Its public materials say it serves professionals and the general public through educational programs, seminars, workshops, conferences, and meetings that discuss psychedelics and mental health. The organization also presents itself as a platform for experts, psychiatrists, psychotherapists, and interested individuals. Its public-facing role is explicitly tied to psychedelic medicine and policy change, with advocacy for strictly controlled therapeutic access and support for scientific research on psychedelics. The site highlights content on MDMA-assisted psychotherapy, psilocybin-assisted psychotherapy, and ayahuasca research, and notes that psychedelic use is illegal in Serbia under the Law on Psychoactive Controlled Substances. Public materials also suggest collaboration interests around early access programs and international non-profit networking in the psychedelic field.

Community organization focused on outreach and public education related to psychedelic topics.

The Norwegian Association for Psychedelic Science advances psychedelic science as a responsible, interdisciplinary, evidence-based field through knowledge dissemination, professional dialogue, and collaboration between research, clinical practice, and society.

Polish Psychedelic Society, or Polskie Towarzystwo Psychodeliczne, is a Polish initiative that emerged in 2019 within the Polish Drug Policy Network. It operates in Poland and appears to serve a national audience of researchers, clinicians, activists, and people interested in psychedelic science and policy. Its core activities are to popularize evidence-based knowledge about psychedelics, support scientific research, and create an interdisciplinary forum for discussion. The organization combines public education with policy advocacy around psychedelic regulation, including decriminalization, legal status reform, harm reduction education, and legal support for people charged with possession for personal use. It also describes itself as working to improve access to medical cannabis in Poland, which is adjacent to broader controlled-substance reform. Documented collaboration areas include research translation, clinician education, policy briefing, patient-facing education, and coalition work on rational drug regulation.

Community organization focused on outreach and public education related to psychedelic topics.

Psychedelic Grad is an informational website about (becoming a) psychedelic researcher. The website hosts files, a blog, and forum.

Community organization focused on outreach and public education related to psychedelic topics.

Psychedelic Seminars is an educational conversation series dedicated to deepening awareness of the benefits, risks, and complexities of psychedelics. They offer a variety of events and programs that bring together experts from a range of disciplines to explore the science, culture, and history of t…

Psychedelic Society Belgium is a Belgium-based nonprofit community organization founded in 2020 and centered in Meise, Belgium. It operates nationally within Belgium and appears to focus on public education, community building, and discussion around psychedelics and psychedelic-assisted mental health care. Its website describes it as a community dedicated to advancing psychedelics and invites participation through events, membership, volunteering, and donations. Its stated mission is to advocate for psychedelic-assisted mental health care and to create a legal framework for the safe and therapeutic use of psychedelics in Belgium. The organization also says it aims to inform the public objectively, support Belgian research, and provide harm-reduction information on legality, safety, and set and setting. Its current visible activity includes monthly meetups, a webinar series, journal clubs, lectures, and a 2026 symposium in Brussels focused on integrity, ethics, and harm reduction in psychedelic therapy.

Psychedelic Society Croatia promotes research, education, and ethical application of psychedelics in mental health.

National-level community network in Germany connecting local psychedelic societies, talks, meetups, and educational channels across multiple cities.

Digital-first psychedelic media platform publishing podcasts, video content, newsletters, and online storytelling for professional and public audiences.

SPACE is a Portuguese scientific association founded in May 2021 by psychiatry physicians. It is based in Portugal and appears to operate primarily as a national scientific and educational association focused on psychedelic medicine. Its public-facing work centers on studying, disseminating, and building knowledge about the therapeutic properties and uses of psychedelic substances, especially in clinical mental health settings. SPACE frames part of its role as supporting regulation and clinical guidance for psychedelic use, while also promoting ethical practice, collaboration with scientific and governmental bodies, and outreach to health professionals, patient associations, and the general public. The organization also publishes educational resources and scientific content on psychedelics and related topics, including ketamine, psilocybin, LSD, MDMA, ayahuasca, and ibogaine. Its current web presence suggests active educational programming and field-building rather than direct service delivery or formal political campaigning.

La Société psychédélique française est une association basée en France qui se présente comme un espace de médiation culturelle et scientifique autour du psychédélisme. Elle vise surtout un public de chercheurs, d’étudiants et de personnes intéressées par les questions scientifiques, culturelles et de réduction des risques liées aux substances psychédéliques. Son activité est principalement nationale, avec des antennes et événements dans plusieurs villes françaises. Dans le champ des psychédéliques, son rôle est centré sur l’éducation publique, la mise en réseau de personnes du milieu académique et de la santé, et l’organisation d’événements de discussion ou d’étude. L’association a notamment organisé une première journée d’étude universitaire sur les études psychédéliques en France et propose des cercles d’intégration et des ressources de réduction des risques. Elle peut être pertinente pour des collaborations autour de la recherche, de la médiation scientifique, de la formation, et du dialogue entre chercheurs, cliniciens, et communautés d’usagers.

Students for Sensible Drug Policy is a global youth-led network focused on drug policy reform, with chapters and affiliates in the United States and other countries. It organizes students, young professionals, and emerging advocates through campus chapters, community chapters, and ambassador activities. Its core work includes policy advocacy, public education, and local organizing around drug laws and campus policies. SSDP is explicitly engaged in psychedelic policy reform as part of its broader drug policy agenda. Current documented efforts include its Psychedelic Policy Reform work, the Psychedelic Pipeline for career development and mentorship, and sponsorship of the North Carolina Psychedelic Policy Coalition. The group also works on blocking restrictions on psychedelic research chemicals and on broader reform areas such as harm reduction, decriminalization, and student-facing drug education.

UK not-for-profit community organization delivering events, learning programs, integration circles, and knowledge resources for psychedelic-informed personal and cultural development.

Netherlands community education organization offering public-facing psychedelic events, talks, and society-building initiatives.

The Ukrainian Psychedelic Research Association is a non-profit organization based in Ukraine that promotes legal psychedelic-assisted therapy and scientific research on psychedelics. Its public materials describe a national focus on Ukraine, with outreach framed around doctors, the military, and society more broadly. The organization says it works within current law and emphasizes ethics, scientific rigor, and evidence-based practice. UPRA presents its field role as advancing clinical use and research for people affected by trauma, especially patients with post-traumatic stress disorder who have not benefited from conventional therapy. It also says it seeks to help veterans, displaced people, and bereaved communities, and to support legislative regulation, expanded access programs, professional training, and patient and caregiver support. Publicly visible current work includes regulatory dialogue, education, professional development, and collaboration on launching the first clinical trials of MDMA and other psychedelics in Ukraine.